Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance

NCT04624568 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
81
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier Régional d'Orléans